Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Leuprorelin Mesilate
2. Leuprorelin Mesylate
3. Camcevi
4. 8e3c3c493w
5. Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 Mesylate
6. Pglu-his-trp-ser-tyr-d-leu-leu-arg-pro-nhc2h5 Methanesulfonate
7. 1-9-luteinizing Hormone-releasing Factor (swine), 6-d-leucine-9-(n-ethyl-l-prolinamide)-, Methanesulfonate (1:1)
8. 944347-41-5
9. Unii-8e3c3c493w
10. Schembl4075500
11. Chembl4802223
12. Leuprorelin Mesilate [who-dd]
13. Leuprolide Mesylate [orange Book]
14. Q27270242
Molecular Weight | 1305.5 g/mol |
---|---|
Molecular Formula | C60H88N16O15S |
Hydrogen Bond Donor Count | 16 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 32 |
Exact Mass | 1304.63357734 g/mol |
Monoisotopic Mass | 1304.63357734 g/mol |
Topological Polar Surface Area | 494 Ų |
Heavy Atom Count | 92 |
Formal Charge | 0 |
Complexity | 2480 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?